Pulmonary Arterial Hypertension (PAH) is an often-overlooked yet life-altering disease that affects thousands globally, requiring lifelong management, rigorous monitoring, and substantial emotional ...

Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly ...

The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...

Karnataka government allocates ₹9,000 crore for white-topping 1,682 km of Bengaluru roads, addressing traffic issues ...

A systematic review of quality-of-life tools available specifically for pulmonary arterial hypertension (PAH) reveals that although several instruments demonstrate strong psychometric properties ...

Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix ...

Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

Mysuru: The public works department has submitted a proposal to the state govt for the upgradation of 12 arterial roads ...